Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Pharmaceutical R&D Leaders Set To Convene

Pharmaceutical Strategy Series
Posted on: 21 Jan 05

Newton, MA January 13, 2005-On February 9-11, 2005 Cambridge Healthtech Institute
in conjunction with PA Consulting will be hosting The Pharmaceutical Leadership Summit, the flagship event of the Pharmaceutical Strategy Series ( This event will be held at Disney's Grand Floridian Resort & Spa where twenty-three R&D leaders at top pharmaceutical and biotech organizations will present on "Strategies To Improve R&D Productivity". Almost all of the top pharmaceutical companies in world have confirmed their participation.

This unique qualified attendance conference is designed to ensure the audience consists of true decision-makers with experience dealing with the strategic issues that face pharmaceutical executives.

The following is a complete list of the leaders presenting at the event:

Dr. Jay Anderson, Eli Lilly and Co., Rick Bayney, Ph.D., Johnson & Johnson, Dr. Matthew Bell, Wyeth Research, Dr. Chris Chamberlain, Roche Products, Dennis Engers, Sanofi-Aventis, Xavier Frapaise, M.D., TAP Pharmaceuticals, Rainer Fuchs, Ph.D., Biogen IDEC
Gianni Gromo, M.D., F. Hoffmann-La Roche Ltd., Dr. Stephen Hutchins, Merck & Co., Charles Jaffe, M.D., Ph.D., AstraZeneca, Shama Kajiji, Pfizer, Inc., Jan-Anders Karlsson, Ph.D., Bayer Healthcare AG, Ismail Kola, Ph.D., Merck Research Laboratories, Michael N. Liebman, Ph.D., Windber Research Institute, Christopher A. Lipinski, Ph.D., Pfizer Global R&D, Jan Malek, PA Consulting Group, Ronald C. Newbold, PhD., Dr. Adrian Otte, Pfizer, Inc., James Resch, Ph.D., AstraZeneca, Robert R. Ruffolo, Ph.D., Wyeth Pharmaceuticals, Wyeth Corporation, Dr. R. Christopher Seaton, Bayer Pharmaceuticals, James B. Summers, Ph.D., Abbott Laboratories, Dr. Wim Swyzen, Johnson & Johnson.

The Pharmaceutical Strategy Series has a proven track record of delivering solution driven presentations that address the most pressing issues confronting R&D leaders. This event brings together best this series has to offer.

About PSS

The Pharmaceutical Strategy Series conferences have been designed to help assess business opportunities and enhance corporate value within the rapidly changing pharmaceutical and biotechnology industries. The PSS Advisory Board is made up of senior level managers at many of the world’s leading pharmaceutical companies including Johnson & Johnson, Merck, Novartis, Eli Lilly, Amgen, AstraZeneca, Aventis and Biogen. The Advisory Board assists in pinpointing exactly the most topical issues to cover and when to cover them. For more details visit

About CHI

Cambridge Healthtech Institute is dedicated to producing conferences that service the life science community. Our conferences provide valuable new insights and competing points of view on the very latest developments within the pharmaceutical and biomedical industry. Each year, CHI holds 70 conferences that bring together leaders from their respective discipline. In the past 14 years, CHI has produced over 400 conferences, attracting more than 50,000 attendees from around the world. For more details visit

For program related inquiries contact: Jim MacNeil at

To obtain presses pass to this event contact: Lisa Cardinale at

For a media partnership contact: Jim MacNeil at

For additional information contact:

Cambridge Healthtech Institute
1037 Chestnut Street
Newton Upper Falls, MA 02464


For more information:

Editor's Details

Jim MacNeil

Last updated on: 27/08/2010

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.